Indicators

Markets:

News

Latest News about BPMC

Recent news which mentions BPMC

< Previous 1 2 3 4 5 Next >

Where Blueprint Medicines Stands With Analysts

August 03, 2022

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

August 02, 2022

Blueprint Medicines: Q2 Earnings Insights

August 02, 2022

A Preview Of Blueprint Medicines's Earnings

August 01, 2022

3 Biotech Stock Picks From This Wedbush Analyst

July 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

July 08, 2022

This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'

June 30, 2022

What 7 Analyst Ratings Have To Say About Blueprint Medicines

June 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

June 27, 2022

SVB Leerink Maintains Market Perform Rating for Blueprint Medicines: Here's What You Need To Know

June 13, 2022

10 Biggest Price Target Changes For Monday

June 13, 2022

91 Biggest Movers From Friday

June 13, 2022

44 Stocks Moving In Friday's Mid-Day Session

June 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022

June 10, 2022

4 Analysts Have This to Say About Blueprint Medicines

June 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

June 01, 2022

10 Biggest Price Target Changes For Wednesday

June 01, 2022

What 3 Analyst Ratings Have To Say About Blueprint Medicines

May 19, 2022

3 Small-Caps That Might Be Acquisition Candidates

May 09, 2022

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs

May 03, 2022

Blueprint Medicines: Q1 Earnings Insights

May 03, 2022

Earnings Preview: Blueprint Medicines

May 02, 2022

Blueprint Medicines Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET

April 27, 2022

Where Blueprint Medicines Stands With Analysts

April 13, 2022

2 Under-the-Radar Biotech Stocks to Buy in 2022

April 11, 2022

After Encouraging Data, Blueprint Medicines Plans Combination Cohort In Tagrisso Resistant Lung Cancer

April 11, 2022

7 Biotech Stocks to Buy With Key Catalysts for April

April 05, 2022

Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks

March 09, 2022

What 5 Analyst Ratings Have To Say About Blueprint Medicines

March 01, 2022

Stocks That Hit 52-Week Lows On Tuesday

March 01, 2022

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.